Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-Time Monitoring and Modeling of Symptoms and Adverse Events in Lung Cancer Patients Receiving Oral Targeted Therapies for Tumors With Actionable Mutations

NCT05370469 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT05370469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05370469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-Time Monitoring and Modeling of Symptoms and Adverse Events in Lung Cancer Patients Receiving Oral Targeted Therapies for Tumors With Actionable Mutations
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 25, 2022
Completion date
May 31, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alk gene mutation, braf, egfr, egfr gene mutation, kras mutation-related tumors, lung cancer, met gene mutation, ret gene mutation, ros1 gene mutation